332 related articles for article (PubMed ID: 11440782)
1. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin.
Rodríguez-Cuevas S; Barroso-Bravo S; Almanza-Estrada J; Cristóbal-Martínez L; González-Rodríguez E
Arch Med Res; 2001; 32(4):273-6. PubMed ID: 11440782
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma.
Gaudy C; Richard MA; Folchetti G; Bonerandi JJ; Grob JJ
J Cutan Med Surg; 2006; 10(3):115-21. PubMed ID: 17241586
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy.
Heller R; Jaroszeski MJ; Glass LF; Messina JL; Rapaport DP; DeConti RC; Fenske NA; Gilbert RA; Mir LM; Reintgen DS
Cancer; 1996 Mar; 77(5):964-71. PubMed ID: 8608491
[TBL] [Abstract][Full Text] [Related]
4. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma.
Glass LF; Jaroszeski M; Gilbert R; Reintgen DS; Heller R
J Am Acad Dermatol; 1997 Oct; 37(4):596-9. PubMed ID: 9344200
[TBL] [Abstract][Full Text] [Related]
5. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry.
Rotunno R; Campana LG; Quaglino P; de Terlizzi F; Kunte C; Odili J; Gehl J; Ribero S; Liew SH; Marconato R; Brizio M; Curatolo P
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1147-1154. PubMed ID: 29178483
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin-mediated electrochemotherapy of basal cell carcinoma.
Glass LF; Fenske NA; Jaroszeski M; Perrott R; Harvey DT; Reintgen DS; Heller R
J Am Acad Dermatol; 1996 Jan; 34(1):82-6. PubMed ID: 8543699
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin.
Heller R; Jaroszeski MJ; Reintgen DS; Puleo CA; DeConti RC; Gilbert RA; Glass LF
Cancer; 1998 Jul; 83(1):148-57. PubMed ID: 9655305
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-mediated electrochemotherapy of metastatic melanoma.
Glass LF; Pepine ML; Fenske NA; Jaroszeski M; Reintgen DS; Heller R
Arch Dermatol; 1996 Nov; 132(11):1353-7. PubMed ID: 8915314
[TBL] [Abstract][Full Text] [Related]
9. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results.
Mevio N; Bertino G; Occhini A; Scelsi D; Tagliabue M; Mura F; Benazzo M
Tumori; 2012; 98(3):308-13. PubMed ID: 22825505
[TBL] [Abstract][Full Text] [Related]
10. Predicting patients at risk for pain associated with electrochemotherapy.
Quaglino P; Matthiessen LW; Curatolo P; Muir T; Bertino G; Kunte C; Odili J; Rotunno R; Humphreys AC; Letulé V; Marenco F; Cuthbert C; Albret R; Benazzo M; De Terlizzi F; Gehl J
Acta Oncol; 2015 Mar; 54(3):298-306. PubMed ID: 25591818
[TBL] [Abstract][Full Text] [Related]
11. Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer.
Jamsek C; Sersa G; Bosnjak M; Groselj A
Radiol Oncol; 2020 Feb; 54(1):79-85. PubMed ID: 32074076
[TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases.
Campana LG; Mali B; Sersa G; Valpione S; Giorgi CA; Strojan P; Miklavcic D; Rossi CR
Br J Oral Maxillofac Surg; 2014 Dec; 52(10):957-64. PubMed ID: 25183266
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area.
Kristiansson S; Reizenstein J; von Beckerath M; Landström F
Acta Otolaryngol; 2019 Feb; 139(2):195-200. PubMed ID: 30734631
[TBL] [Abstract][Full Text] [Related]
14. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.
Solari N; Spagnolo F; Ponte E; Quaglia A; Lillini R; Battista M; Queirolo P; Cafiero F
J Surg Oncol; 2014 Mar; 109(3):270-4. PubMed ID: 24165992
[TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma.
Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L
G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201
[TBL] [Abstract][Full Text] [Related]
16. Electroporation therapy for head and neck cancer including carotid artery involvement.
Allegretti JP; Panje WR
Laryngoscope; 2001 Jan; 111(1):52-6. PubMed ID: 11192900
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of electrochemotherapy in ulcerated basal cell carcinoma.
Richetta AG; Curatolo P; D'Epiro S; Mancini M; Mattozzi C; Giancristoforo S; Rotunno R; Calvieri S
Clin Ter; 2011; 162(5):443-5. PubMed ID: 22041802
[TBL] [Abstract][Full Text] [Related]
18. Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head.
Spugnini EP; Pizzuto M; Filipponi M; Romani L; Vincenzi B; Menicagli F; Lanza A; De Girolamo R; Lomonaco R; Fanciulli M; Spriano G; Baldi A
J Vet Intern Med; 2015; 29(5):1368-75. PubMed ID: 26192904
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.
Caracò C; Mozzillo N; Marone U; Simeone E; Benedetto L; Di Monta G; Di Cecilia ML; Botti G; Ascierto PA
BMC Cancer; 2013 Dec; 13():564. PubMed ID: 24289268
[TBL] [Abstract][Full Text] [Related]
20. Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors.
Byrne CM; Thompson JF
Expert Rev Anticancer Ther; 2006 May; 6(5):671-8. PubMed ID: 16759159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
